Clinical Research Directory
Browse clinical research sites, groups, and studies.
RAD ONC FREEDOM Oncology Pain
Sponsor: Jonsson Comprehensive Cancer Center
Summary
The investigators propose to conduct a study in medically refractory cancer pain patients utilizing radiosurgery to ablate the pituitary hypophysis, as well as neuromodulate the centromedian and parafascicular complexes within the thalami - the so-called triple target. This involves treating the pituitary hypophysis and thalamus to a dose of 90 Gy. These patients will have previously failed to achieve adequate pain control with opioid pain regimens and interventional approaches. The trial will involve a multidisciplinary approach involving radiation oncology, neurosurgery, palliative care, and medical oncology colleagues across UCLA.
Official title: Functional Radiosurgery for Easing or Eliminating Debilitating Oncologic Morbidity (FREEDOM)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
19
Start Date
2026-06-01
Completion Date
2029-06-01
Last Updated
2026-05-26
Healthy Volunteers
No
Conditions
Interventions
Radiosurgery
intracranial functional stereotactic radiosurgery (FnSRS) to the triple target: centromedian-parafasciular complex bilaterally, and the hypophysis
Locations (1)
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States